Fundraising Fox
/Companies
Sign in

Aveta Biomics

Bedford, US · Founded 2013 · Delaware corporation

Find your way into Aveta Biomics

362 people in our graph share verified history with the Aveta Biomics team — schools, employers, funds. One of them is your warm intro.

John Warnerunlockedknows Parag Mehta · together at Polaroid Corporation (overlapped)
×5knows the team · via Polaroid Corporation
×6knows the team · via Bentley University

Aveta Biomics develops cancer therapeutics based on Orthologous Molecular Structures (OMS), metabolites from organisms with orthologous genes and processes, combined using an evolutionary-biology-based platform. Its drugs aim to treat and prevent cancers while addressing tumor heterogeneity and drug resistance.

BiotechDeep TechHealthtech

Founders & leadership

PMParag Mehta
Parag MehtaCEOExecutive officer and director at Aveta Biomics, with background spanning business development, product development, manufacturing, and venture capital financing across advanced materials, imaging, clean technology, and biotechnology sectors.
SM
Sharmila MudgalNamed on SEC filing

Board

SP
S. P. KothariBoard director
BTBharat Tewarie
Bharat TewarieBoard director
PDPeter Dolan
Peter DolanBoard director
DPDavid Page
David PageBoard director

Reported raises · per SEC filings

Form D private placements

$6.2M disclosed across 3 rounds · 2018–2024

▶$4.5MraisedMar 2025 · 36 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • S. P. KothariDirector
  • Parag MehtaExecutive Officer, Director
  • Bharat TewarieDirector
  • Peter DolanDirector
  • David PageDirector
Offering amount
$8M
Amount sold
$4.5M
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$600KraisedFeb 2022 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Parag MehtaExecutive Officer, Director
  • Guha BalaDirector
  • Bharat TewarieDirector
Offering amount
$5M
Amount sold
$600K
First sale
Feb 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMar 2018 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sharmila MudgalExecutive Officer, Director
  • Parag MehtaExecutive Officer, Director
  • SP KothariDirector
Offering amount
$2.5M
Amount sold
$1.1M
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Bioworld9 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Doximity9 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.

Companies competing with Aveta Biomics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Aveta Biomics do?
Aveta Biomics develops cancer therapeutics based on Orthologous Molecular Structures (OMS), metabolites from organisms with orthologous genes and processes, combined using an evolutionary-biology-based platform. Its drugs aim to treat and prevent cancers while addressing tumor heterogeneity and drug resistance.
How much funding has Aveta Biomics raised?
Aveta Biomics has disclosed $6.2M raised across 3 rounds.
Where is Aveta Biomics headquartered?
Aveta Biomics is headquartered in Bedford, US.